Broad, Broader, Broadest: Drug Delivery Start-Ups
This article was originally published in Start Up
Executive Summary
Drug delivery start-ups abound, despite the harsh environment for new biopharmaceutical companies. Drug delivery deals are increasing, as are relatively highly valued acquisitions, as larger drug delivery or service companies seek to broaden their tool kits. But for companies who haven't yet proven themselves, dealmaking is difficult in a variety of ways. Credibility is tough to achieve.